Showing results (961-970 of 1,014) with videos related to
Sort By:
Pageof 102
Plos One|December 2, 2014
Burden and correlates of geriatric depression in the Uyghur elderly population, observation from Xinjiang, ChinaLei Feng, Ping Li, Chen Lu, et al.Nature Communications|February 10, 2025
Unveiling charge utilization mechanisms in ferroelectric for water splittingJie Zhang, Yong Liu, Thomas Dittrich, et al.Signal Transduction and Targeted Therapy|January 5, 2025
A pan-immune panorama of bacterial pneumonia revealed by a large-scale single-cell transcriptome atlasKun Xiao, Yan Cao, Zhihai Han, et al.Leukemia|January 18, 2022
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemiaXiuli Wang, Zhenyuan Dong, Dennis Awuah, et al.Bone Research|February 24, 2025
CCN2 mediates fibroblast-macrophage interaction in knee arthrofibrosis based on single-cell RNA-seq analysisZiyun Li, Jia Jiang, Kangwen Cai, et al.Journal for Immunotherapy of Cancer|August 11, 2025
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumorsAnthony K Park, Isabel Monroy, Yuwei Ren, et al.Breast Cancer Research and Treatment|December 2, 2022
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II studyBinghe Xu, Tao Sun, Yanxia Shi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.American Journal of Hematology|September 2, 2022
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trialYi Zhang, Hu Zhou, Zhongxing Jiang, et al.Molecular Therapy. Methods & Clinical Development|May 16, 2022
Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccineMin Guan, Laura Lim, Leo Holguin, et al.Pageof 102